people's bank of china digital currency Top stories

On the disk, the big consumer sector led the rise all day, with retail, ice and snow tourism, food and beverage, household items and other directions rising sharply; Real estate stocks performed in intraday trading, with Tiandiyuan and Hualian shares trading daily; The pharmaceutical biological sector was active at the beginning of the session, with Haixin shares, First Medicine and Panlong Pharmaceutical trading daily.Guosheng Financial Holdings recently announced that the company has received the "Acceptance Form for Administrative License Application of China Securities Regulatory Commission" issued by China Securities Regulatory Commission, and the CSRC has accepted the application for administrative license for the merger of Guosheng Securities by Guosheng Financial Holdings. The merger and acquisition still needs the approval of the CSRC, and there are uncertainties about whether and when the relevant approval can be obtained and the final implementation completion time. The company will disclose the progress in a timely manner in accordance with relevant regulations.

On the disk, the big consumer sector led the rise all day, with retail, ice and snow tourism, food and beverage, household items and other directions rising sharply; Real estate stocks performed in intraday trading, with Tiandiyuan and Hualian shares trading daily; The pharmaceutical biological sector was active at the beginning of the session, with Haixin shares, First Medicine and Panlong Pharmaceutical trading daily.Guolian Securities recently announced that the M&A Review Committee of Shanghai Stock Exchange is scheduled to hold the 6th M&A Review Committee review meeting in 2024 on December 17th to review the company's application for this transaction.On the disk, the big consumer sector led the rise all day, with retail, ice and snow tourism, food and beverage, household items and other directions rising sharply; Real estate stocks performed in intraday trading, with Tiandiyuan and Hualian shares trading daily; The pharmaceutical biological sector was active at the beginning of the session, with Haixin shares, First Medicine and Panlong Pharmaceutical trading daily.

Guolian Securities recently announced that the M&A Review Committee of Shanghai Stock Exchange is scheduled to hold the 6th M&A Review Committee review meeting in 2024 on December 17th to review the company's application for this transaction.Looking forward to the market outlook, Guohai Securities said that the upside of the index has been opened, and Hong Kong stocks, as the leading indicator, may be more flexible with the blessing of the Fed's interest rate cut. Stylistically, the market is dominated by stages at the end of the year, and the SSE 50 is at a low level relative to the small-cap style. The recent value style is expected to remain strong driven by "insurance capital allocation+policy expectation".The big consumption sector has become the strongest main line of the market.